Vitamin D and melanoma incidence and mortality

Pigment Cell and Melanoma Research

Volumn 26, Issue 1, 2013, Pages 9-15

  Berwick, Marianne ^a   Erdei, Eszter O ^a  

^a UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

Incidence; Melanoma; Mortality; Ultraviolet radiation

Indexed keywords

25 HYDROXYVITAMIN D; SUNSCREEN; VITAMIN D;

BODY MASS; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER SURVIVAL; DIETARY INTAKE; HEREDITY; HUMAN; LIFESTYLE; MELANOMA; NOTE; OBESITY; PIGMENTATION; RADIATION EXPOSURE; RISK FACTOR; SUN EXPOSURE; ULTRAVIOLET RADIATION; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

DIETARY SUPPLEMENTS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; MELANOMA; PIGMENTATION; RISK FACTORS; SKIN NEOPLASMS; SUNSCREENING AGENTS; ULTRAVIOLET RAYS; VITAMIN D;

EID: 84871443118     PISSN: 17551471     EISSN: 1755148X     Source Type: Journal    
DOI: 10.1111/pcmr.12015     Document Type: Note

References (68)

1. Armas, L.A., Dowell, S., Akhter, M., Duthuluru, S., Huerter, C., Hollis, B.W., Lund, R., and Heaney, R.P. (2007). Ultraviolet-B radiation increases serum 25-hydroxyvitamin D levels: the effect of UVB dose and skin color. J. Am. Acad. Dermatol. 57, 588-593.
2. Asgari, M.M., Maruti, S.S., Kushi, L.H., and White, E. (2009). A cohort study of vitamin D intake and melanoma risk. J. Invest. Dermatol. 129, 1675-1680.
3. Autier, P., Dore, J.-F., Eggermont, A.M.M., and Coebergh, J.W. (2011). Epidemiological evidence that UVA radiation is involved in the genesis of cutaneous melanoma. Curr. Opin. Oncol. 23, 189-196.
4. Barroso, E., Fernandez, L.P., Milne, R.L. et al. (2008). Genetic analysis of the vitamin D receptor gene in two epithelial cancers: melanoma and breast cancer case-control studies. BMC Cancer 8, 385.
5. Berwick, M., Armstrong, B.K., Ben-Porat, L., Fine, J., Kricker, A., Eberle, C., and Barnhill, R. (2005). Sun exposure and mortality from melanoma. J. Natl Cancer Inst. 297, 195-199.
6. Bogh, M.K.B., Schmedes, A.V., Philipsen, P.A., Thieden, E., and Wulf, H.C. (2011). Interdependence between body surface area and ultraviolet B dose in vitamin D production: a randomized controlled trial. Br. J. Dermatol. 164, 163-169.
7. Brock, K., Huang, W.-Y., Fraser, D.R. et al. (2010). Low vitamin D status is associated with physical inactivity, obesity and low vitamin D intake in a large US sample of healthy middle-aged men and women. J. Steroid Biochem. Mol. Biol. 121, 462-466.
8. Chatzinasiou, F., Lill, C.M., Kypreou, K. et al. (2011). Comprehensive field synopsis and systematic meta-analyses of genetic association studies in cutaneous melanoma. J. Natl Cancer Inst. 103, 1227-1235.
9. Colston, K.W., Colson, M.J., and Feldman, D. (1981). 1, 25-hydroxyvitamin D3 and malignant melanoma: the presence of receptors and inhibition of cell growth in culture. Endocrinology 108, 1083-1086.
10. Coney, P., Demers, L.M., Dodson, W.C., Kunselman, A.R., Ladson, G., and Legro, R.S. (2012). Determination of vitamin D in relation to body mass index and race in a defined population of black and white women. Int. J. Gynaecol. Obstet. 119, 21-5.
11. Danielsson, C., Fehsel, K., Polly, P., and Carlberg, C. (1998). Differential apoptotic response of human melanoma cells to 1 alpha, 25-dihydroxyvitamin D3 and its analogues. Cell Death Differ. 5, 946-952.
12. Davies, J.R., Chang, Y.M., Snowden, H. et al. (2011). The determinants of serum vitamin D levels in participants in a melanoma case-control study living in a temperate climate. Cancer Causes Control 22, 1471-1482.
13. Demetriou, S.K., Ona-Vu, K., Teichert, A.E., Cleaver, J.E., Bikle, D.D., and Oh, D.H. (2012). UV and Vitamin D Receptor mediates DNA repair and is UV inducible in intact epidermis but not in cultured keratinocytes. J. Invest. Dermatol. 132, 2097-2100.
14. Denzer, N., Vogt, T., and Reichrath, J. (2011). Vitamin D receptor (VDR) polymorphisms and skin cancer: a systematic review. Dermato-endocrinology 3, 205-210.
15. Drané, P., Compe, E., Catez, P., Chymkowitch, P., and Egly, J.M. (2004). Selective regulation of vitamin D receptor-responsive genes by TFIIH. Mol. Cell 16, 187-197.
16. Drincic, A.T., Armas, L.A.G., Van Diest, E.E., and Heaney, R.P. (2012). Volumetric dilution, rather than sequestration best explains the low vitamin D status of obesity. Obesity 20, 1444-1448.
17. Egan, K.M. (2009). Vitamin D and melanoma. Ann. Epidemiol. 19, 455-461.
18. Evans, S.R.T., McGarry Houghton, A., Schumaker, L., Brenner, R.V., Buras, R.R., Davoodi, F., Nauta, R.J., and Shabahag, M. (1996). Vitamin D receptor and growth inhibition by 1, 25-dihydroxyvitamin D3 in human malignant melanoma cell lines. J. Surg. Res. 61, 12-133.
19. Frampton, R.J., Omond, S.A., and Eisman, J.A. (1983). Inhibition of human cancer cell growth by 1, 25-dihydroxyvitamin D3 metabolites. Cancer Res. 43, 4443-4447.
20. Gambichler, T., Bindsteiner, M., Höxtermann, S., and Kreuter, A. (2012). Serum 25-hydroxyvitamin D serum levels in a large German cohort of melanoma patients. Br. J. Dermatol. Epub ahead of print, August 9.
21. Gandini, S., Raimondi, S., Gnagnarella, P., Doré, J.-F., Maisonneuve, P., and Testori, A. (2009). Vitamin D and skin cancer: a meta-analysis. Eur. J. Cancer 45, 634-641.
22. Gapska, P., Scott, R.J., Serrano-Fernandez, P., et al. (2009). Vitamin D receptor variants and the malignant melanoma risk: a population based study. Cancer Epidemiol. 33, 103-107.
23. Gerber, B., Mathys, P., Moser, M., Bressoud, D., and Braun-Fahrländer, C. (2002). Ultraviolet emission spectra of sunbeds. Photocohem. Photobiol. 76, 664-668.
24. Giovannucci, E., Liu, Y., Rimm, E.B., Hollis, B.W., Fuchs, C.S., Stampfer, M.J., and Willett, W. (2006). Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J. Natl Cancer Inst. 98, 451-459.
25. Glerup, H., Mikkelsen, K., Pulsen, L., Hass, E., Overbeck, S., Charles, P., and Eriksen, E.F. (2000). Commonly recommended daily intake of vitamin D is not sufficient if sunlight exposure is limited. J. Intern. Med. 247, 260-268.
26. Halsall, J.A., Osborne, J.E., Potter, L., Pringle, J.H., and Hutchinson, P.E. (2004). A novel polymorphism in the 1A promoter region of the vitamin D receptor is associated with altered susceptibility and prognosis in malignant melanoma. Br. J. Cancer 91, 765-770.
27. Han, J., Colditz, G.A., and Hunter, D.J. (2007). Polymorphisms in the MTHFR and VDR genes and skin cancer risk. Carcinogenesis 28, 390-397.
28. Hoesl, M., Dietz, K., Rocken, M., and Berneburg, M. (2010). Vitamin D levels of XP-patients under stringent sun protection. Eur J Dermatol 20, 457-460.
29. Hofmann, J.N., Yu, K., Horst, R.L., Hayes, R.B., and Purdue, M.P. (2010). Long-term variation in serum 25-hydroxyvitamin D concentration among participants in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Cancer Epidemiol. Biomarkers Prev. 19, 927-931.
30. Hutchinson, P.E., Osborne, J.E., Lear, J.T., Smith, A.G., Bowers, P.W., Morris, P.N., Jones, P.W., York, C., Strange, R.C., and Fryer, A.A. (2000). Vitamin D receptor polymorphisms are associated with altered prognosis in patients with malignant melanoma. Clin. Cancer Res. 6, 498-504.
31. IARC. International Agency for Research on Cancer Working Group on Artificial Ultraviolet (UV) Light and Skin Cancer (2007). The association of use of sunbeds with cutaneous malignant melanoma and other skin cancers: a systematic review. Int. J. Cancer 120, 1116-1122.
32. Jorde, R., Sneve, M., Hutchinson, M., Emaus, N., Figenschau, Y., and Grimnes, G. (2010). Tracking of serum 25-hydroxyvitamin D levles during 14 years in a population-based study, and during 12 months in an intervention study. Am. Epidemiol. J. 171, 903-908.
33. Lazovich, D., Vogel, R.I., Berwick, M., Weinstock, M.A., Anderson, K.E., and Warshaw, E.M. (2010). Indoor tanning and risk of melanoma: a case-control study in a highly exposed population. Cancer Epidemiol. Biomarkers Prev. 19, 1557-1568.
34. Li, C., Liu, Z., Zhang, Z. et al. (2007). Genetic variants of the vitamin D receptor gene alter risk of cutaneous melanoma. J. Invest. Dermatol. 127, 276-280.
35. Linos, E., Keiser, E., Kanzler, M., Sainani, K.L., Lee, W., Vittinghoff, E., Chren, M.M., and Tang, J.Y. (2012). Sun protective behaviors and vitamin D levels in the US population: NHANES 2003-2006. Cancer Causes Control 23, 133-140.
36. Lips, P., Chapuy, M.C., Dawson-Hughes, B., Pols, H.A., and Holick, M.F. (1999). An international comparison of serum 25-hydroxyvitamin D measurements. Osteoporos. Int. 9, 394-397.
37. Mai, X.-M., Chen, Y., Camargo, C.A., and Langhammer, A. (2012). Cross-sectional and prospective cohort study of serum 25-hydroxyvitamin D level and obesity in adults. The HUNT study. Am. J. Epidemiol. 175, 1029-1036.
38. Major, J.M., Kiruthu, C., Weinstein, S.J., Horst, R.L., Syder, K., Virtamo, J., and Albanes, D. (2012). Pre-diagnostic circulating vitamin D and risk of melanoma in men. PLoS ONE 7, e35112.
39. Mandelcorn-Monson, R., Marrett, L., Kricker, A. et al., and for the GEM Study (2011). Sun exposure, vitamin D receptor polymorphisms FokI and BsmI and risk of multiple primary melanoma. Cancer Epidemiol. 35, e105-e110.
40. Marks, R., Foley, P.A., Jolley, D., Knight, K.R., Harrison, J., and Thompson, S.C. (1995). The effect of regular sunscreen use on vitamin D levels in an Australian population. Arch. Dermatol. 131, 415-421.
41. Mason, R.S., Pryke, A.M., Ranson, M., Thomas, H.E., and Posen, S. (1988). Human melanoma cells: functional modulation by calciotropic hormones. J. Invest. Dermatol. 90, 834-840.
42. Millen, A.E., Tucker, M.A., Hartge, P., Halpern, A., Elder, D.E., Guerry 4th, D., Holly, E.A., Sagebiel, R.W., and Potschman, N. (2004). Diet and melanoma in a case-control study. Cancer Epidemiol. Biomarkers Prev. 13, 1042-1051.
43. Moan, J., Lagunova, Z., Cicarma Em Aksnes, L., Dahlback, A., Grant, W.B., and Porojnicu, A.C. (2009). Sunbeds as vitamin D sources. Photochem. Photobiol. 85, 1474-1479.
44. Mocellin, S., and Nitti, D. (2008). Vitamin D receptor polymorphisms and the risk of cutaneous melanoma: a systematic review and meta-analysis. Cancer 113, 2398-2407.
45. Murphy, A.B., Kelley, B., Nyame, Y.A., Martin, I.K., Smith, D.J., Castaneda, L., Zagaja, G.J., Hollowell, C.M., and Kittles, R.A. (2012). Predictors of serum vitamin D levels in African American and European American men in Chicago. Am. J. Mens Health 6, 420-426.
46. Nesby-O'Dell, S., Scanlon, K.S., Cogswell, M.E., Gillespie, C., Hollis, B.W., Looker, A.C., Allen, C., Doughtertly, C., Gunter, E.W., and Bowman, B.A. (2002). Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination Survey, 1988-1994. Am. J. Clin. Nutr. 76, 187-192.
47. Newton-Bishop, J.A., Beswick, S., Randerson-Moor, J. et al. (2009). Serum 25-hydroxyvitamin D3 levels are associated with Breslow thickness at presentation and survival from melanoma. J. Clin. Oncol. 27, 5439-5444.
48. Nilsen, L.T.N., Aalerud, T.N., Hannevik, M., and Veierod, M.B. (2012). High UVA exposure from sunbeds. Pigment Cell Melanoma Res. Epub ahead of print, August 6.
49. Nowak, M., Harrison, S.L., Buettner, P.G., Kimlin, M., Porter, D., Kennedy, L., and Speare, R. (2011). Vitamin D status of adults from tropical Australia determined using two different laboratory assays: implications for public health messages. Photochem. Photobiol. 87, 935-943.
50. Nürnberg, B., Gräber, S., Gärtner, B., Geisel, J., Pföhler, C., Schadendorf, D., Tilgen, W., and Reichrath, J. (2009). Reduced serum 25-hydroxyvitamin D levels in stage IV melanoma patients. Anticancer Res. 29, 3669-3674.
51. Orlow, I., Roy, P., Reiner, A.S. et al. (2012). Vitamin D receptor polymorphisms in patients with cutaneous melanoma. Int. J. Cancer 130, 405-418.
52. Povey, J.E., Darakhshan, F., Robertson, K. et al. (2007). DNA repair gene polymorphisms and genetic predisposition to cutaneous melanoma. Carcinogenesis 28, 1087-1093.
53. Randerson-Moor, J.A., Taylor, J.C., Elliott, F. et al. (2009). Vitamin D receptor gene polymorphisms, serum wt-hydroxyvitamin D levels, and melanoma: UK case-control comparisons and a meta-analysis of published VDR data. Eur. J. Cancer 45, 3271-3281.
54. Reichrath, J., and Quering, K. (2004). No evidence for reduced 25-hydoxyvitamin D serum levels in melanoma patients. Letter.. Cancer Causes Control 15, 97-98.
55. Rosso, S., Sera, F., Segnan, N., and Zanetti, R. (2008). Sun exposure prior to diagnosis is associated with improved survival in melanoma patients: results from a long-term follow-up study of Italian patients. Eur. J. Cancer 44, 1275-1281.
56. Santonocito, C., Capizzi, R., Concolino, P. et al. (2007). Association between cutaneous melanoma, Breslow thickness and vitamin D receptor BsmI polymorphism. Br. J. Dermatol. 156, 277-282.
57. Schäfer, A., Emmert, S., Kruppa, J. et al. (2012). No association of vitamin D metabolism-related polymorphisms and melanoma risk as well as melanoma prognosis: a case-control study. Arch. Dermatol. Res. 304, 353-361.
58. Sempos, C.T., Vesper, H.W., Phinney, K.W., Thienpont, L.M., and Coates, P.M. (2012). Vitamin D status as an international issue: national surveys and the problem of standardization. Scand. J. Clin. Lab. Invest. Suppl. 243, 32-40.
59. Shipman, A.R., Clark, A.B., and Levell, N.J. (2011). Sunnier European countries have lower melanoma mortality. Clin. Exp. Dermatol. 36, 544-547.
60. Tang, J.Y., Fu, T., LeBlanc, E., Manson, J.A.E., Feldman, D., Linos, E., Vitolins, M.Z., Zeitouni, N.C., Larson, J., and Stefanick, M.L. (2011). Calcium plus vitamin D supplementation and the risk of nonmelanoma and melanoma skin cancer: post hoc analyses of the women's health initiative randomized controlled trial. J. Clin. Oncol. 29, 30078-30084.
61. Thieden, E., Philipsen, P.A., and Wulf, H.C. (2006). Ultraviolet radiation exposure pattern in winter compared with summer based on time-stamped personal dosimeter readings. Br. J. Dermatol. 154, 133-138.
62. Thieden, E., Jorgensen, H., Jorgensen, N., Philipsen, P., and Wulf, H.C. (2008). Sunbed radiation provokes skin vitamin D synthesis. Photochem. Photobiol. 84, 1487-1492.
63. Vinceti, M., Malagoli, C., Fiorentini, C. et al. (2011). Inverse association between dietary vitamin D and risk of cutaneous melanoma in a northern Italy population. Nutr. Cancer 63, 506-513.
64. Wang, S.Q., Setlow, R., Berwick, M., Polsky, D., Marghoob, A.A., Kopf, A.W., and Bart, R.S. (2001). Ultraviolet A and melanoma: a review. J. Am. Acad. Dermatol. 44, 837-846.
65. Ward, K.A., Lazovich, D.A., and Hordinsky, M.K. (2012). Germline melanoma susceptibility and prognostic genes: a review of the literature. J. Am. Acad. Dermatol. Epub ahead of print, May 12.
66. Weinstock, M.A., Stampfer, M.J., Lew, R.A., Willett, W.C., and Sober, A.J. (1992). Case-control study of melanoma and dietary vitamin D: implications for advocacy of sun protection and sunscreen use. J. Invest. Dermatol. 98, 809-811.
67. Yang, L., Lof, M., Veierod, M.B., Sandin, S., Adami, H.-O., and Weiderpass, E. (2011). Ultraviolet exposure and mortality among women in Sweden. Cancer Epidemiol. Biomarkers Prev. 20, 683-690.
68. Yudoh, K., Matsuno, H., and Kimura, T. (1999). 1alpha, 25-dihydroxyvitamin D3 inhibits invasiveness through the extracellular matrix and in vivo pulmonary metastasis of B16 mouse melanoma. J. Lab. Clin. Med. 133, 120-128.